» Articles » PMID: 25522352

Canadian Orofacial Pain Team Workshop Report on the Global Year Against Orofacial Pain

Overview
Journal Pain Res Manag
Date 2014 Dec 19
PMID 25522352
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The year 2013-2014 has been designated the Global Year Against Orofacial Pain by the International Association for the Study of Pain. Accordingly, a multidisciplinary Canadian and international group of clinical, research and knowledge-transfer experts attended a workshop in Montreal, Quebec. The workshop had two aims: to identify new pathways for innovative diagnosis and management of chronic orofacial pain states; and to identify opportunities for further collaborative orofacial pain research and education in Canada. Three topics related to chronic orofacial pain were explored: biomarkers and pain signatures for chronic orofacial pain; misuse of analgesic and opioid pain medications for managing chronic orofacial pain; and complementary alternative medicine, topical agents and the role of stress in chronic orofacial pain. It was determined that further research is needed to: identify biomarkers of chronic orofacial post-traumatic neuropathic pain, with a focus on psychosocial, physiological and chemical-genetic factors; validate the short- and long-term safety (i.e., no harm to health, and avoidance of misuse and addiction) of opioid use for two distinct conditions (acute and chronic orofacial pain, respectively); and promote the use of topical medications as an alternative treatment in dentistry, and further document the benefits and safety of complementary and alternative medicine, including stress management, in dentistry. It was proposed that burning mouth syndrome, a painful condition that is not uncommon and affects mainly postmenopausal women, should receive particular attention.

Citing Articles

Postoperative Analgesic and Anti-inflammatory Effectiveness of Ginger (Zingiber officinale) and NSAIDs as Adjuncts to Nonsurgical Periodontal Therapy for the Management of Periodontitis.

Alshibani N, Al-Kattan R, Alssum L, Basudan A, Shaheen M, AlQutub M Oral Health Prev Dent. 2022; 20:227-232.

PMID: 35695692 PMC: 11641444. DOI: 10.3290/j.ohpd.b3125633.


Effectiveness of Curcumin in Reducing Self-Rated Pain-Levels in the Orofacial Region: A Systematic Review of Randomized-Controlled Trials.

Sterniczuk B, Rossouw P, Michelogiannakis D, Javed F Int J Environ Res Public Health. 2022; 19(11).

PMID: 35682028 PMC: 9180889. DOI: 10.3390/ijerph19116443.


Retrospective Study on Ganglionic and Nerve Block Series as Therapeutic Option for Chronic Pain Patients with Refractory Neuropathic Pain.

Gerken J, Fritzsche T, Denke C, Schafer M, Tafelski S Pain Res Manag. 2020; 2020:6042941.

PMID: 32774567 PMC: 7399767. DOI: 10.1155/2020/6042941.


Knowledge About Chronic Orofacial Pain Among General Dentists of Kermanshah, Iran.

Rezaei F, Sharifi R, Shahrezaee H, Mozaffari H Open Dent J. 2017; 11:221-229.

PMID: 28553411 PMC: 5427728. DOI: 10.2174/1874210601711010221.


Multimodal management of dental pain with focus on alternative medicine: A novel herbal dental gel.

Kumarswamy A Contemp Clin Dent. 2016; 7(2):131-9.

PMID: 27307656 PMC: 4906852. DOI: 10.4103/0976-237X.183066.

References
1.
Calandre E, Navajas-Rojas M, Ballesteros J, Garcia-Carrillo J, Garcia-Leiva J, Rico-Villademoros F . Suicidal ideation in patients with fibromyalgia: a cross-sectional study. Pain Pract. 2014; 15(2):168-74. DOI: 10.1111/papr.12164. View

2.
Lotsch J, Doehring A, Mogil J, Arndt T, Geisslinger G, Ultsch A . Functional genomics of pain in analgesic drug development and therapy. Pharmacol Ther. 2013; 139(1):60-70. DOI: 10.1016/j.pharmthera.2013.04.004. View

3.
Madadi P, Hildebrandt D, Lauwers A, Koren G . Characteristics of opioid-users whose death was related to opioid-toxicity: a population-based study in Ontario, Canada. PLoS One. 2013; 8(4):e60600. PMC: 3618438. DOI: 10.1371/journal.pone.0060600. View

4.
Mooiman K, Maas-Bakker R, Hendrikx J, Bank P, Rosing H, Beijnen J . The effect of complementary and alternative medicines on CYP3A4-mediated metabolism of three different substrates: 7-benzyloxy-4-trifluoromethyl-coumarin, midazolam and docetaxel. J Pharm Pharmacol. 2014; 66(6):865-74. DOI: 10.1111/jphp.12208. View

5.
Spector M, Kummet C, Holmes D . Complementary and alternative medicine in predoctoral dental curricula: an exploratory survey of U.S. dental schools. J Dent Educ. 2013; 77(12):1610-5. View